Objective: To examine whether hypercapnia in very low birth weight (VLBW) infants during the first 3 days of life is associated with severe intraventricular hemorrhage (IVH).
Introduction
Although the etiology of neonatal brain injury is multifactorial, disturbances of cerebral blood flow (CBF) and cerebral autoregulation play an important role. [1] [2] [3] We recently observed that increasing PaCO 2 in ventilated very low birth weight (VLBW) infants during the first week of life is associated with progressively impaired cerebral autoregulation. 4 Further, hypercapnia in animals has been shown to abolish intact cerebral autoregulation. 5, 6 In addition to low gestational age, low birth weight, male gender, worse acute lung disease, etc., hypercapnia has also been identified as an important risk factor for intraventricular hemorrhage (IVH), [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] the most common acute brain injury of premature infants. Although it is unclear whether hypercapnia causes IVH or results from circulatory disturbances that follow severe IVH, hypercapnia may influence the development of IVH by causing vasodilation of cerebral resistance arterioles, increasing CBF, and by impairing intact cerebral autoregulation. [4] [5] [6] 17, 18 A majority of the published studies reporting an association between hypercapnia and IVH were performed in the pre-surfactant era, where goals for ventilation 19, 20 were different than that currently recommended. 21 Before the surfactant era, hypercapnia was likely a proxy for the sickest infants with the most severe respiratory distress syndrome. We therefore initiated a retrospective study of inborn VLBW infants born during the surfactant and permissive hypercapnia eras with the objective of determining if hypercapnia during the early neonatal period was still associated with IVH. Based on our previous studies, 4, 18 we hypothesized that hypercapnia (maximum PaCO 2 ) in VLBW infants during the first 3 days of life is still associated with severe IVH.
Methods

Subjects
All VLBW infants born at the University of Arkansas for Medical Sciences, the tertiary care hospital for the state of Arkansas, between January 1999 and May 2004 were included if they survived at least 72 h, were free of serious congenital anomalies, had arterial access for X72 h, had X9 arterial blood gases (ABGs) obtained during this period, and had X1 cranial ultrasound. Excluded infants did not have arterial access during the first 72 h of life. Routine intensive care procedures including decisions regarding mode of mechanical ventilation and timing of ABGs and cranial ultrasounds were at the discretion of the attending neonatologist. The study was approved by the University of Arkansas for Medical Sciences Institutional Review Board.
Data collection
Neonatal (time and date of birth, birth weight, gestational age, race, gender, multifetal gestation, intrauterine growth restriction, and Apgar scores at 1 and 5 min) and maternal characteristics (age, prenatal care, antenatal steroids, mode of delivery, chorioamnionitis, preterm premature rupture of the membranes, placental abruption, pregnancy induced hypertension, and exposure to magnesium), neonatal interventions (high-frequency ventilation, conventional ventilation, days intubated, surfactant doses, vasopressor use, indomethacin, or surgical treatment for patent ductus arteriosus), neonatal outcomes (survival, pneumothorax, chronic lung disease, and worst grade of IVH), and all PaCO 2 values with dates and times during the first 72 h of life were obtained for each infant from a retrospective chart review.
Definitions
Gestational age was estimated based on obstetrical criteria (last menstrual period, ultrasound confirmation, etc.) and neonatal criteria. 22 If there was >2 weeks discrepancy between the obstetrical and the neonatal estimates, the neonatal estimate was used. Prenatal care was defined as X1 visit. Antenatal steroids were noted if the mother received any steroids before delivery. Preterm premature rupture of the membranes was defined as rupture X18 h before delivery. Survival was defined as survival to hospital discharge. Chronic lung disease was defined as the requirement for supplemental oxygen at X36 weeks gestation. Worst grade IVH was determined using the staging criteria of Papile et al. 23 on any cranial ultrasound during the first 7 days of life. (If a cranial ultrasound was not obtained during the fourth through seventh days of life, results from the next ultrasound were also used to classify the worst grade IVH.) Pneumothorax was defined as the presence of free air in the pleural cavity diagnosed by needle thoracentesis and/or chest X-ray. Finally, a multiple logistic regression model was built using a purposeful selection method advocated by Hosmer and Lemeshow. 24 The primary reason for choosing this method is that at each step of the modeling process, the analyst is in control of the decision making rather than yielding that control to an automated algorithm in a statistical software package. A brief overview of the method follows:
Statistical analyses
1. A univariate logistic regression model was fit for each of the clinically meaningful variables. 2. All statistically significant variables from Step 1 were included in a multiple logistic regression model. 3. A reduced multiple logistic regression model was fit after removing the apparently statistically non-informative variables. The likelihood ratio test was then performed to examine the statistical significance of the variables removed. 4.
Step 3 was repeated until a model was found containing only the statistically significant variables. 5. One at a time, each of the variables that were not found to be univariately statistically significant in Step 1 was added back to the model identified in Step 4 in order to determine whether it was statistically significant at this point. 6. 'Clinically plausible' statistical interactions were identified, and a similar process was followed as outlined in Steps 1-4 to determine if any of those interaction terms should be included in the final multiple logistic regression model. Infants not having arterial access for X72 h (n ¼ 373) had birth weight and gestational age 1176±259 g and 30.0±2.5 weeks, respectively. In these infants, there were 29 infants with grade 1 IVH, nine with grade 2 IVH, five with grade 3 IVH, and one with grade 4 IVH (six with severe IVH). Mean birth weight, mean gestational age, and mean level of worst grade of IVH were significantly different between the excluded and study infants (P<0.001).
For maximum PaCO 2 ( Table 2 ) and percentage of PaCO 2 values X60 mm Hg of the study sample, the medians were significantly different among infants with the five IVH grades (P<0.001). On the other hand, medians of minimum PaCO 2 and the percentage of values X55 mm Hg were not different among the five grades of IVH (P ¼ 0.852 and P ¼ 0.069, respectively). Figure 1 shows the predicted unadjusted probability of suffering from severe IVH according to maximum PaCO 2 level for the study sample. As maximum PaCO 2 increases, the risk of severe IVH increases. For example, as maximum PaCO 2 in our sample increases from 40 to 100 mm Hg, the probability of severe IVH increases from about 8 to 21%. Very low birth weight infants with severe IVH compared to those without severe IVH were significantly lighter at birth, less mature, greater proportion of multiple births, had lower Apgar scores, and were ventilated longer (Table 3) . There was no difference in race, gender, receipt of antenatal steroids, delivery mode, and magnesium exposure between the two groups.
The final multiple logistic regression model consisted of the following predictors of severe IVH (Table 4) : gestational age (weeks), gender (female vs male), Apgar score at 1 min (dichotomized into two groups: >3 vs p3), multifetal gestation, use of vasopressors, and maximum PaCO 2 (categorized into four groups based on its quartiles). All but gender, Apgar score at 1 min, and use of vasopressors were statistically significant predictors of severe IVH. Gender was kept in the model because it was considered a clinically important confounder. Apgar score at 1 min and use of vasopressors were kept in the model because they were deemed to be statistically important even though they did not strictly qualify at the a ¼ 0.05 level of statistical significance. Holding all other variables in the model constant, the odds of having severe IVH decreased by 19% for each 1-week increase in gestational age. Being part of a multifetal gestation increased the odds of having a severe IVH by 87%. To be complete, Table 5 shows the unadjusted odds ratios for factors not in the final model.
The distribution of maximum PaCO 2 values for the study group is illustrated in Figure 2 . The vertical reference lines represent the 25th (56 mm Hg), 50th (63 mm Hg), and 75th (75 mm Hg) percentiles. The odds of having a severe IVH for infants with maximum PaCO 2 values between the 25th percentile and the median (63 mm Hg) were 3.08 times greater than the odds for infants with maximum PaCO 2 values p the 25th percentile (PaCO 2 quartile 1; 95% CI: (1.07, 8.88)). Moreover, the odds of having a severe IVH for infants with maximum PaCO 2 values between the median and the 75th percentile were 3.95 times greater than the odds for infants with a maximum PaCO 2 in quartile 1 (95% CI: (1.41, 11.1)). Finally, the odds of having a severe IVH for infants with maximum PaCO 2 values >the 75th percentile were 4.67 times greater than the odds for infants with a maximum PaCO 2 in quartile 1 (95% CI: (1.71, 12.8)).
Discussion
The main objective in this retrospective study was to examine whether hypercapnia during the surfactant and permissive hypercapnia eras was still associated with severe IVH. To our knowledge, this is the first report suggesting that maximum PaCO 2 during the first 72 h of life is a dose-dependent predictor for severe IVH in VLBW infants. This is concerning given our recent observations that increasing PaCO 2 levels in VLBW infants are associated with progressively impaired cerebral autoregulation. 4 As impaired cerebral autoregulation in premature infants is associated with brain injury, 2,3 hypercapnia may influence the development of severe IVH by vasodilating cerebral resistance arterioles and increasing CBF, and possibly overwhelming the integrity of the germinal matrix vessels causing them to rupture. 17, 18 Further, hypercapnia may abolish or impair cerebral autoregulation, causing the cerebral vasculature to be at risk for ischemia or hyperperfusion during fluctuations of blood pressure. Consistent with our results, most studies examining the relationship between hypercapnia and IVH identified a positive univariate association. It was first demonstrated in 1978 that umbilical PaCO 2 was significantly greater in premature infants subsequently diagnosed with IVH compared to those without IVH. 7 Cooke observed that VLBW infants with IVH had significantly higher maximum PaCO 2 during each day of the first week of life compared to those without IVH. 9 Further, VLBW infants with early IVH diagnosed by 6 h of age had significantly higher peak PaCO 2 during the first 36 h of age. Notably, van 10 in multivariate analyses a significant association was not found. 10, 11, 15 Only one small observational trial using multivariate analysis found that hypercapnia was a statistically significant antecedent to IVH. 12 In contrast, three trials found no association between hypercapnia and IVH. The first study failing to find a relationship included premature infants born from 1981 to 1984; 25 the subsequent two published studies involved premature infants born during the surfactant era. 26, 27 In glaring contrast to previous studies, hypocapnia, not hypercapnia, was observed by Erickson et al. 26 to be an important risk factor for severe IVH or periventricular leukomalacia in ventilated premature infants born from 1992 to 1994. In the third study, hypocapnia during the first day of life was actually found to be protective against IVH. Inconsistency in results between studies is likely due to the inclusion of infants of different gestational ages and birth weights, various proportions of outborn infants, different sample sizes, and changing goals for ventilation. Disparate criteria for IVH and different PaCO 2 cutoffs were often used, as well as many of the studies only used univariate analysis. We were surprised to find that some of our infants had severe hypercapnia during the period when we targeted PaCO 2 levels of 45 to 55 mm Hg 21 in the care of ventilated VLBW infants. We investigated all medical records of infants with extreme values and could not exclude any due to laboratory error. Further, while most of the extreme values were present on the second day of life when frequency of intermittent ABGs was reduced, we also noted that several elevated PaCO 2 values were obtained within 20 min of surfactant administration. 18 Importantly, we could not identify any particular complications (tube obstruction, pulmonary hemorrhage, IVH, etc.) that were temporally related to the extreme values. During the initial randomized controlled pilot trial of permissive hypercapnia, when adherence to reference PaCO 2 goals can be assumed to be excellent, infants randomized to mild hypercapnia also experienced inadvertent severe hypercapnia (maximum PaCO 2 of 52±24 mm Hg). 21 Further, in the observational trial by Cooke, infants with IVH had PaCO 2 as high as 141 mm Hg. 9 Our findings of an association between hypercapnia and severe IVH during the first 72 h of life must be tempered by limitations of our retrospective study design. First, enrolled infants were smaller, less mature, sicker, had worse acute respiratory disease, and had worse IVH compared to excluded infants. Thus, results of this study cannot be generalized to all VLBW infants. However, in order to determine if an association between PaCO 2 levels during the first 3 days of life and severe IVH exists, one must examine infants who had a minimum number of ABGs during the study period. Another problem is that more frequent ABGs are typically obtained in sicker and unstable infants. Some VLBW infants did not have an arterial catheter attempted, and many had arterial access removed before 72 h of age. In this retrospective analysis, we were unable to control duration of arterial access and frequency of ABG determination. Even if we performed a prospective study, it would be unethical to require a minimum number of ABGs or to require arterial access for X72 h, especially if neonatologists deemed them unnecessary. Next, we did not observe an effect of antenatal steroids on development of severe IVH. This may be because a large proportion of our premature infants received antenatal steroids, or possibly because we did not have information on whether infants received partial or full courses. We were also unable to determine if duration of hypercapnia or fluctuation of PaCO 2 was associated with severe IVH. The proportion of PaCO 2 values X60 mm Hg is only a weak proxy of duration of hypercapnia, since intermittent ABG determination became more infrequent as time went on and critical values could have been missed. The most accurate way to determine if duration of hypercapnia and fluctuation of PaCO 2 is associated with brain injury is to use continuous ABG monitoring and calculate area under the curve and coefficient of variation. Lastly, while we observed a dose-dependent association between maximum PaCO 2 and severe IVH, we could not determine the causal pathway. It is unclear whether hypercapnia precedes the development of IVH, results from the circulatory disturbances that may follow severe IVH, or may be a combination of the two. In this retrospective study, we were unable to obtain cranial ultrasound data near birth and at critical times that would have enabled us to at least suggest a 'cause and effect' relationship. However, a majority of infants experienced their worst grade IVH during the first week of life, when early hypercapnia may have been associated.
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We have observed that maximum PaCO 2 during the first 72 h of life dose-dependently increases the probability of severe IVH in a cohort of VLBW infants during the permissive hypercapnia era. While these results are thought provoking, we could not determine causality nor could we determine the cause of hypercapnia. Perhaps, hypercapnia during the surfactant and permissive hypercapnia eras still characterizes infants with the most severe acute lung disease. Additional studies in this realm are clearly warranted. Further statistical evaluation of the permissive hypercapnia trials 21, 28 may also aid in determining a PaCO 2 threshold or range that, if used, could decrease the probability of severe IVH.
